最新报道:MEI Pharma has invested $100 million in Litecoin through a private equity round, emerging as a major institutional holder. The biotech firm is pivoting toward crypto, reflecting corporate treasury diversification trends. Litecoin's price rose following the announcement, driven by MEI's investment rather than broader market movements. The company also appointed Litecoin co-founder Charlie Lee to its board, reinforcing long-term commitment. While similar to MicroStrategy's strategy, MEI's Litecoin-focused approach sets a new precedent.